PNC Financial Services Group’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-57
Closed -$146 4942
2024
Q1
$146 Hold
57
﹤0.01% 4628
2023
Q4
$116 Sell
57
-9,943
-99% -$18.1K ﹤0.01% 4512
2023
Q3
$17.2K Hold
10,000
﹤0.01% 3501
2023
Q2
$19.5K Hold
10,000
﹤0.01% 3571
2023
Q1
$27.8K Hold
10,000
﹤0.01% 3325
2022
Q4
$34.5K Hold
10,000
﹤0.01% 3190
2022
Q3
$26K Hold
10,000
﹤0.01% 3336
2022
Q2
$24K Sell
10,000
-44
-0.4% -$116 ﹤0.01% 3418
2022
Q1
$41K Buy
10,044
+10,000
+22,727% +$53K ﹤0.01% 3220
2021
Q4
$1K Hold
44
﹤0.01% 4344
2021
Q3
$0 Hold
44
﹤0.01% 4433
2021
Q2
$0 Hold
44
﹤0.01% 4306
2021
Q1
$0 Sell
44
-15
-25% -$207 ﹤0.01% 4229
2020
Q4
$0 Buy
+59
New +$178 ﹤0.01% 4093

Other funds holding GRTS

PNC Financial Services Group's GRTS Position: Q2 2024 in Review

PNC Financial Services Group sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2024, closing a stake of 57 shares — an estimated $146 sold.

PNC Financial Services Group first reported a position in GRTS in Q4 2020 and held it in 14 quarters. The position peaked at $41K in Q1 2022. 79 funds tracked by Wall St. Rank hold GRTS as of Q2 2024.

  • PNC Financial Services Group reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • PNC Financial Services Group sold 57 Gritstone bio, Inc. Common Stock shares in Q2 2024, an estimated $146.
  • PNC Financial Services Group first reported a position in Gritstone bio, Inc. Common Stock in Q4 2020 and held it in 14 quarters.
  • PNC Financial Services Group's Gritstone bio, Inc. Common Stock position peaked at $41K in Q1 2022.
  • 79 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2024.

Based on PNC Financial Services Group's 13F filing for Q2 2024, filed 9 Aug 2024.